Infections with Trichuris trichiura are among the most common causes of intestinal parasitism in children worldwide, and the diagnosis is based on microscopic egg identification in the chronic phase of the infection. During parasitism, the adult worm of the trichurid nematode maintains its anterior region inserted in the intestinal mucosa, which causes serious damage and which may open access for gut microorganisms through the intestinal tissue. The immune-regulatory processes taking place during the evolution of the chronic infection are still not completely understood. By use of the Swiss Webster outbred mouse model, mice were infected with 200 eggs, and tolerance to the establishment of a chronic Trichuris muris infection was induced by the administration of a short pulse of dexamethasone during nematode early larval development. The infected mice presented weight loss, anemia, an imbalance of the microbiota, and intense immunological cell infiltration in the large intestine. It was found that mice have a mixed Th1/Th2/Th17 response, with differences being found among the different anatomical locations. After 45 days of infection, the parasitism induced changes in the microbiota composition and bacterial invasion of the large intestine epithelium. In addition, we describe that the excretory-secretory products from the nematode have anti-inflammatory effects on mouse macrophages cultured in vitro, suggesting that T. muris may modulate the immune response at the site of insertion of the worm inside mouse tissue. The data presented in this study suggest that the host immune state at 45 days postinfection with T. muris during the chronic phase of infection is the result of factors derived from the worm as well as alterations to the microbiota and bacterial invasion. Taken together, these results provide new information about the parasite-host-microbiota relationship and open new treatment possibilities.
Brazilian flora includes numerous species of medicinal importance that can be used to develop new drugs. Plant tissue culture offers strategies for conservation and use of these species allowing continuous production of plants and bioactive substances. Annona mucosa has produced substances such as acetogenins and alkaloids that exhibit antimicrobial activities. The widespread use of antibiotics has led to an increase in multidrug-resistant bacteria, which represents a serious risk of infection. In view of this problem, the aim of this work was to evaluate the antibacterial potential of extracts of A. mucosa obtained by in vitro techniques and also cultured under in vivo conditions. Segments from seedlings were inoculated onto different culture media containing the auxin picloram and the cytokinin kinetin at different concentrations. The calluses obtained were used to produce cell suspension cultures. The materials were subjected to methanol extraction and subsequent fractionation in hexane and dichloromethane. The antimicrobial activity against 20 strains of clinical relevance was evaluated by the macrodilution method at minimum inhibitory and minimum bactericidal concentrations. The extracts showed selective antimicrobial activity, inhibiting the growth of Streptococcus pyogenes and Bacillus thuringiensis at different concentrations. The plant tissue culture methods produced plant materials with antibacterial properties, as well as in vivo grown plants. The antibacterial activity of material obtained through biotechnological procedures of A. mucosa is reported here for the first time.
The presence of multi-drug resistant (MDR) E. coli harboring virulence pathotypes in aquatic systems is a public health concern due to an increase number of cases of infections and outbreaks in industrialized and developing countries. The aim of the present study was to evaluate the microbiological quality of Joana river, located at Rio de Janeiro, by analyzing E. coli bacteria contamination and to investigate virulence properties and MDR profiles by phenotypic and genotypic methods, including bacterial interaction with Caco-2 cells. A total of 34 E. coli were identified by MALDI-TOF and 20 E. coli were characterized as MDR when submitted to antimicrobial susceptibility test. Evaluation by multiplex-PCR of MDR E. coli demonstrated the presence of virulence pathotypes: EHEC (stx1, stx2, eae genes), STEC (stx2 gene) and EIEC/STEC (stx2, iaL genes). Virulence potential was demonstrated by the ability to adhere and survive within Caco-2 cells of MDR E. coli pathotypes (n = 4). In conclusion, this study demonstrates the presence of diarrheagenic MDR E. coli in river water at Rio de Janeiro. The possibility of aquatic environment dissemination of antimicrobial resistance and human contamination leading to community and nosocomial infections due to virulent MDR E. coli water-borne pathogens is a matter of concern.
Last-resort antibiotics act as ultimate force to overcome multidrug-resistant strains infections. Cases of tigecycline resistance in gram-negative bacilli in clinical settings are reported worldwide, however, there is no data related to tigecycline resistant strains in river water. This study demonstrates seven tigecycline gram-negative bacilli isolated from river water in Rio de Janeiro metropolitan area, their resistance genes, ability of biofilm formation with/without antibiotics and behavior using the nematode Caenohabidits elegans as infection in vivo model. From 24 gram-negative isolated strains, 16 (66.6%) were classified as multidrug-resistant, however, seven (29.1%) presented resistant to all antimicrobial agents tested, including tigecycline and have been identified by MALDI-TOF as A. baumannii, E. aerogenes and P. agglomerans. All tigecycline-resistant strains presented amplification products for ESBL, AME and PMQR
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.